Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02654418 · ClinicalTrials.gov registry record · NA
Safety Study of SIC 8000 in Subjects Undergoing Endoscopic Mucosal Resection (EMR) of Colonic Lesions Equal to or Larger Than 2 cm
A NA study of Adenomas, sponsored by Cosmo Technologies.
- Completed
- Registry status
- NA
- Development phase
- 226
- Enrollment target
- 5
- Study locations
NCT02654418: Completed NA study of Adenomas, sponsored by Cosmo Technologies.
NCT02654418 is a NA study of Adenomas that has completed, run by Cosmo Technologies. The registered enrollment target is 226 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02654418, a NA study of Adenomas, has completed, sponsored by Cosmo Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 226 participants
- Enrollment target
- 5
- Study locations
Study Summary
SIC 8000 is indicated for use in gastrointestinal endoscopic procedures for submucosal lift of polyps, adenomas, early-stage cancers or other gastrointestinal mucosal lesions, prior to excision with a snare.
Conditions Studied
Interventions
- PROCEDURE Endoscopic Mucosal Resection of large colon polyps (greater than or equal to 20 mm in size)
Study Locations (5)
Other
- Humanitas Research Hospital & Humanitas University - Milan
- Queen Alexandra Hospital - Portsmouth
Florida
- Mayo Clinic - Jacksonville
Indiana
- Indiana University Hospital - Indianapolis
Missouri
- Kansas City VA Hospital - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 226 participants |
| Start Date | 2016-02 |
| Est. Completion | 2017-07 |
| Phase | NA |
What the finished NCT02654418 record still lists
NCT02654418 is an interventional study that assigns participants to a tested intervention. The registered 226 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).
The record links to 1 condition, with Adenomas appearing as the primary indexed condition, and to 1 intervention - of which Endoscopic Mucosal Resection of large colon polyps (greater than or equal to 20 mm in size) is the first listed.
NCT02654418 lists 5 locations in 4 states (Other, Florida, Indiana).
Frequently Asked Questions
What is clinical trial NCT02654418 about?
NCT02654418 is a clinical study titled "Safety Study of SIC 8000 in Subjects Undergoing Endoscopic Mucosal Resection (EMR) of Colonic Lesions Equal to or Larger Than 2 cm". SIC 8000 is indicated for use in gastrointestinal endoscopic procedures for submucosal lift of polyps, adenomas, early-stage cancers or other gastrointestinal mucosal lesions, prior to excision with a snare.
What is the current status of trial NCT02654418?
This trial is currently completed. It is a NA study. The enrollment target is 226 participants. The study started on 2016-02. Estimated completion is 2017-07.
What conditions does trial NCT02654418 study?
This clinical trial studies the following conditions: Adenomas.
What interventions are being tested in trial NCT02654418?
The interventions under investigation include: Endoscopic Mucosal Resection of large colon polyps (greater than or equal to 20 mm in size) (PROCEDURE).
Who is sponsoring clinical trial NCT02654418?
This trial is sponsored by Cosmo Technologies, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02654418 being conducted?
This trial has 5 study locations across Florida, Indiana, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02654418's enrollment target sits among peer trials
226 471st of 2000 higher than 1,529 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04419272 · 226 participants · Phase 4
Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits
- NCT05449002 · 226 participants · NA
Digital Single Session Intervention for Youth Mental Health
- NCT05488054 · 226 participants · NA
Muscle O2 Saturation and Hemoglobin Levels During Rehabilitation From Arthroscopic Surgery
- NCT05924477 · 226 participants · NA
Glaucoma Drainage Device and Endothelial Cell Loss Compare Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia